Gencell Ltd
GNCLF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $5 | $5 |
| % Growth | 0% | -92.3% | 0% | – |
| Cost of Goods Sold | $2 | $2 | $4 | $4 |
| Gross Profit | -$2 | -$2 | $1 | $1 |
| % Margin | -562.4% | -562.4% | 21.3% | 21.3% |
| R&D Expenses | $1 | $1 | $2 | $2 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $3 | $3 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | -$0 | -$0 | -$10 | -$10 |
| Operating Expenses | $4 | $4 | -$5 | -$5 |
| Operating Income | -$6 | -$6 | $6 | $6 |
| % Margin | -1,584.2% | -1,584.2% | 125.5% | 125.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$10 | -$10 |
| Pre-Tax Income | -$6 | -$6 | -$4 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$6 | -$4 | -$4 |
| % Margin | -1,593.7% | -1,593.7% | -83.9% | -83.9% |
| EPS | -0.051 | -0.051 | -0.036 | -0.036 |
| % Growth | 0% | -44.8% | 0% | – |
| EPS Diluted | -0.051 | -0.051 | -0.036 | -0.036 |
| Weighted Avg Shares Out | 111 | 111 | 107 | 107 |
| Weighted Avg Shares Out Dil | 111 | 111 | 109 | 109 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$5 | -$5 | -$4 | -$3 |
| % Margin | -1,352% | -1,352% | -75.9% | -73.5% |